论著

儿童先天性长QT综合征14例临床表型及基因变异分析

  • 孙琪青 ,
  • 陈蒙蒙 ,
  • 付大鹏 ,
  • 何坤 ,
  • 燕笑尘 ,
  • 侯维纳 ,
  • 王芳洁 ,
  • 谢振华 ,
  • 李东晓
展开
  • 1.郑州大学附属儿童医院(河南省儿童医院/郑州儿童医院) 心血管内科(河南郑州 450018)
    2.郑州大学附属儿童医院(河南省儿童医院/郑州儿童医院) 新生儿重症监护室(河南郑州 450018)
    3.郑州大学附属儿童医院(河南省儿童医院/郑州儿童医院) 河南省儿科疾病临床研究中心 河南省儿童神经发育工程研究中心(河南郑州 450018)
谢振华 电子信箱:xzhh0107@163.com

收稿日期: 2024-05-10

  录用日期: 2024-11-27

  网络出版日期: 2025-03-31

基金资助

河南省医学科技攻关计划联合共建项目(LHGJ20230572)

Clinical and genetic analysis of 14 children with congenital long QT syndrome

  • SUN Qiqing ,
  • CHEN Mengmeng ,
  • FU Dapeng ,
  • HE Kun ,
  • YAN Xiaochen ,
  • HOU Weina ,
  • WANG Fangjie ,
  • XIE Zhenhua ,
  • LI Dongxiao
Expand
  • 1. Department of Cardiology, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou 450018, Henan, China
    2. Neonatal Intensive Care Unit, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou 450018, Henan, China
    3. Henan Children's Neurodevelopment Engineering Research Center, Henan Provincial Clinical Research Center for Pediatric Diseases, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou 450018, Henan, China

Received date: 2024-05-10

  Accepted date: 2024-11-27

  Online published: 2025-03-31

摘要

目的 对先天性长QT 综合征(LQTS)患儿临床表型及基因变异谱进行总结分析,探讨LQTS基因型与临床表型的潜在相关性。方法 选取2018年11月至2023年11月心内科收治的14个无亲缘关系的LQTS家系作为研究对象,收集患儿的临床资料,对患儿进行家系全外显子组测序,应用Sanger测序验证候选变异,并对患儿进行治疗和随访。结果 14例患儿中男6例、女8例,中位发病年龄为82.5(37.5~129.8)个月。14例以心跳骤停、晕厥或阿斯综合征发病。共检出5个基因(KCNQ1KCNH2SCN5ACACNA1CCALM1基因)的相关变异,依据美国医学遗传学与基因组学学会(ACMG)相关变异评级指南,变异位点均为致病性变异或可能致病性变异。其中,SCN5A基因(NM_198056.2)c.796C>G(p.Leu266Val)变异既往未见文献报道,依据ACMG指南评级为可能致病变异(PS2+PM2_Supporting+PP3)。14例患儿均用β受体阻滞剂治疗,其中2例联用美西律治疗;随访至2024年3月31日,3例死亡;1例因自行停药而导致阿斯综合征发作1次,余均未再出现晕厥。结论 本研究发现了一个SCN5A基因的新变异c.796C>G(p.Leu266Val),拓展了先天性LQTS相关SCN5A基因变异谱。先天性LQTS发病形式多样,对于疑似LQTS的患儿应进行心电图检查,并结合基因检测可对疾病明确诊断。

本文引用格式

孙琪青 , 陈蒙蒙 , 付大鹏 , 何坤 , 燕笑尘 , 侯维纳 , 王芳洁 , 谢振华 , 李东晓 . 儿童先天性长QT综合征14例临床表型及基因变异分析[J]. 临床儿科杂志, 2025 , 43(4) : 278 -285 . DOI: 10.12372/jcp.2025.24e0468

Abstract

Objective The clinical phenotype and gene variation spectrum of children with congenital long QT syndrome (LQTS) were summarized and analyzed to explore the potential correlation between LQTS genotype and clinical phenotype. Methods Fourteen unrelated LQTS families admitted to the Department of Cardiology from November 2018 to November 2023 were selected as the study objects. The clinical data of the children were collected, whole exome sequencing of family was performed, candidate variants were verified by Sanger sequencing, and the children were treated and followed up. Results The median onset age of the 14 patients (6 boys and 8 girls) was 82.5 (37.5-129.8) months. Fourteen patients started with sudden cardiac arrest, syncope or Adams-Stokes syndrome. A total of 5 genes (KCNQ1, KCNH2, SCN5A, CACNA1C, and CALM1) were detected with variations, and according to the grading standard of the American College of Medical Genetics and Genomics (ACMG), all variations were pathogenic or likely pathogenic. Among them, SCN5A (NM_198056.2) c.796C>G (p.Leu266Val) has not been reported in the literature in the past, and according to the ACMG guidelines, it is determined to be a likely pathogenic variant (PS2+PM2_Supporting+PP3). All 14 children were treated with β-blockers, 2 of whom were also treated with mexiletine. During follow-up until March 31, 2024, there were 3 deaths. One child had an episode of Adams-Stokes syndrome due to self-discontinuation of medication, and the remainder had no further syncope. Conclusions In this study, a novel variant c.796C>G (p.leu266val) of SCN5A gene was found, expanding the spectrum of SCN5A gene variants associated with congenital LQTS. There are various forms of congenital LQTS, and an electrocardiogram should be performed for children with suspected LQTS, which in combination with genetic testing can lead to a definitive diagnosis of the disease.

参考文献

[1] Steinberg C. Diagnosis and clinical management of long-QT syndrome[J]. Curr Opin Cardiol, 2018, 33(1): 31-41.
[2] Neira V, Enriquez A, Simpson C, et al. Update on long QT syndrome[J]. J Cardiovasc Electrophysiol, 2019, 30(12): 3068-3078.
[3] Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013[J]. Heart Rhythm, 2013, 10(12): 1932-1963.
[4] Westphal DS, Burkard T, Moscu-Gregor A, et al. Reclassification of genetic variants in children with long QT syndrome[J]. Mol Genet Genomic Med, 2020, 8(9): e1300.
[5] Hofman N, Jongbloed R, Postema PG, et al. Recurrent and founder mutations in the Netherlands: the long-QT syndrome[J]. Neth Heart J, 2011, 19(1): 10-16.
[6] Kapplinger JD, Tester DJ, Salisbury BA, et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test[J]. Heart Rhythm, 2009, 6(9): 1297-1303.
[7] Marschall C, Moscu-Gregor A, Klein HG. Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders[J]. Cardiovasc Diagn Ther, 2019, 9(Suppl 2): S292-S298.
[8] Ng CA, Perry MD, Liang W, et al. High-throughput phenotyping of heteromeric human ether-à-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants[J]. Heart Rhythm, 2020, 17(3): 492-500.
[9] Fazelifar AF, Pourirahim M, Masoumi T, et al. Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole-exome sequencing[J]. J Arrhythm, 2023, 39(3): 430-453.
[10] Kapplinger JD, Tester DJ, Alders M, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing[J]. Heart Rhythm, 2010, 7(1): 33-46.
[11] Fukuyama M, Ohno S, Ozawa J, et al. High prevalence of late-appearing T-wave in patients with long QT syndrome type 8[J]. Circ J, 2020, 84(4): 559-568.
[12] Sun Q, Xie Z, Wang F, et al. Case report of a child with long QT syndrome type 14 caused by CALM1 gene mutation and literature review[J]. Mol Genet Genomic Med, 2024, 12(1): e2287.
[13] Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death[J]. Eur Heart J, 2022, 43(40): 3997-4126.
[14] Barsheshet A, Dotsenko O, Goldenberg I. Congenital long QT syndromes: prevalence, pathophysiology and management[J]. Paediatr Drugs, 2014, 16 (6): 447-456.
[15] Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy[J]. Heart Rhythm, 2019, 16(11):e301-e372.
[16] Giudicessi JR, Ackerman MJ. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes[J]. Transl Res, 2013, 161(1): 1-14.
[17] Huang H, Kuenze G, Smith JA, et al. Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations[J]. Sci Adv, 2018, 4(3): eaar2631.
[18] Lahtinen AM, Marjamaa A, Swan H, Kontula K. KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?[J]. BMC Med Genet, 2011, 12: 11.
[19] Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome[J]. N Engl J Med, 2003, 348(19): 1866-1874.
[20] Barsheshet A, Goldenberg I, J OU, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome[J]. Circulation, 2012, 125(16): 1988-1996.
[21] Copier JS, Bootsma M, Ng CA, et al. Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance[J]. Hum Mol Genet, 2023, 32(7): 1072-1082.
[22] Tester DJ, Will ML, Haglund CM, et al. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing[J]. Heart Rhythm, 2005, 2(5): 507-517.
[23] 中华医学会心血管病学分会精准心血管病学学组, 中国医疗保健国际交流促进会精准心血管病分会, 中华心血管病杂志编辑委员会. 单基因遗传性心血管疾病基因诊断指南[J]. 中华心血管病杂志, 2019, 47(3): 175-196.
  Section of Precision Cardiovascular Medicine of Chinese Society of Cardiology; Precision Cardiovascular Medicine Branch of China International Exchange; Promotive Association for Medical; Health Care Editorial Board of Chinese Journal of Cardiology. Guideline for the genetic diagnosis of monogenic cardiovascular diseases[J]. Zhonghua Xinxueguanbing Zazhi, 2019, 47(3): 175-196.
[24] 中国生物医学工程学会心律分会. 中国儿童心血管植入性电子器械专家共识[J]. 中国心脏起搏与心电生理杂志, 2023, 37(1): 1-11.
[25] Rohatgi RK, Sugrue A, Bos JM, et al. Contemporary outcomes in patients with long QT syndrome[J]. J Am Coll Cardiol, 2017, 70(4): 453-462.
文章导航

/